Telia Company AB (publ) (TLSNY)

Ligand Pharmaceuticals Revenue

Telia Company AB had revenue of 19.79B SEK in the quarter ending June 30, 2025, a decrease of -1.96%. This brings the company's revenue in the last twelve months to 89.41B, up 5.77% year-over-year. In the year 2024, Telia Company AB had annual revenue of 89.13B with 0.64% growth.

• Revenue (ttm): 89.41B SEK
• Revenue Growth: +5.77%
• P/S Ratio: 1.50
• Revenue / Employee: 5.30M SEK
• Employees: 16,859
• Market Cap: 14.12B USD

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	89.13B	566.00M	0.64%
Dec 31, 2023	88.56B	2.98B	3.48%
Dec 31, 2022	85.58B	-2.76B	-3.13%
Dec 31, 2021	88.34B	-848.00M	-0.95%
Dec 31, 2020	89.19B	3.23B	3.75%